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SUMMARY 
 
Ubiquitin conjugation is an essential process modulating protein function in eukaryotic cells. 
Amazingly, little is known how the progressive assembly of ubiquitin chains is managed by 
the responsible enzymes. Only recently ubiquitin binding activity has emerged as an 
important factor in chain formation. The Ubc7 activator Cue1 carries a ubiquitin binding CUE 
domain, which substantially stimulates K48-linked polyubiquitination mediated by Ubc7. Our 
results from NMR-based analysis and in vitro ubiquitination reactions point out that two 
parameters accelerate ubiquitin chain assembly: the increasing number of CUE binding sites 
and the position of CUE binding within a growing chain. In particular interactions with a 
ubiquitin moiety adjacent to the acceptor ubiquitin facilitate chain elongation. These data 
indicate a mechanism for ubiquitin binding in which Cue1 positions Ubc7 and the distal 
acceptor ubiquitin for rapid polyubiquitination. Disrupting this mechanism results in 
dysfunction of the ERAD pathway by a delayed turnover of substrates. 
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INTRODUCTION 
 
Ubiquitination is a crucial post-translational modification involved in many cellular 
processes. Ubiquitin molecules are transferred to client proteins through the concerted actions 
of ubiquitin activating enzymes (E1), ubiquitin conjugating enzymes (E2) and ubiquitin 
ligases (E3). Ubiquitin itself can be targeted for ubiquitination on seven internal lysine 
residues and on its N-terminus resulting in the assembly of polymeric chains. Distinct chain 
types do not only display different topologies (Komander & Rape, 2012) but are also 
associated with divergent signaling output. For instance, polyubiquitin chains linked via K48 
represent the major signal for proteasomal degradation (Thrower et al., 2000), while K63-
linked chains mediate widespread nonproteasomal functions such as DNA repair, 
transcriptional activation, endocytosis or protein trafficking (Conaway et al., 2002; Haglund, 
K., and Dikic, I., 2005; Huang & D'Andrea, 2006; Chen & Sun, 2009). These various 
polyubiquitin chains are decoded into cellular responses by ubiquitin binding domains (UBD) 
which guide effector proteins to ubiquitinated substrates (Weissman, 2001). UBDs 
specifically distinguish between different polyubiquitin molecules by recognizing the linkage 
and length of chains. Monoubiquitin is bound by UBDs with a KD in the micromolar range, 
whereas polyubiquitin chains provide multiple binding surfaces thus increasing binding 
affinity (Husnjak & Dikic, 2012). 
In contrast to this well-known deciphering function of UBDs the function of ubiquitin binding 
in polyubiquitin chain formation is poorly understood. For instance, activities of the E2 
enzymes Ubc13 (Pastushok et al., 2005), Ube2g1 (Choi et al., 2014) and Cdc34 (Choi et al., 
2010) rely on ubiquitin binding events. In addition it has already been shown that processive 
polyubiquitin chain formation can be promoted by noncovalent interactions of ubiquitin with 
the backside of certain E2 enzymes (Brzovic et al., 2006; Buetow et al., 2015) as well as by 
RING domains showing ubiquitin binding activity (Brown et al., 2014; Wright et al., 2016). 
 4 
Furthermore E4 enzymes have been identified that recognize ubiquitinated proteins and 
elongate the attached ubiquitin chains (Koegl et al., 1999). 
A recent report on polyubiquitination activity in the endoplasmic reticulum associated protein 
degradation (ERAD) pathway revealed that the UBD of Cue1, the CUE domain, stimulates 
ubiquitin chain formation (Bagola et al., 2013). Cue1 contains a C-terminal Ubc7 binding 
region (Kostova et al., 2009; Bazirgan & Hampton, 2008) recruiting Ubc7 to the ER 
membrane (Biederer et al., 1997) for activation (Metzger et al., 2013). Ubc7 acts together 
with different ERAD RING finger ubiquitin ligases, like HRD1, DOA10 and the Asi 
complexes (Bays et al., 2001; Kreft et al., 2006; Khmelinskii et al., 2014; Foresti et al., 2014). 
Substrate proteins are then polyubiquitinated and subsequently removed from the ER 
membrane by an ERAD specific Cdc48 complex. Subsequently, target proteins are escorted 
by adaptor proteins to the proteasome in the cytosol. 
Although polyubiquitin signals play essential roles in many cellular pathways, the molecular 
basis on how they are generated remains elusive. In contrast to single attachments of ubiquitin 
to a substrate, building a ubiquitin chain challenges the E1-E2-E3 cascade with multiple 
conjugation events at the same molecule. This sequential assembly is a spatially dynamic 
process in which the distal tip of a growing chain constantly changes its relative position to 
the active site in the E2-E3 complex. In consequence, chain assembly slows down with 
increasing chain length as shown for example for the APC/C E3 complex (Meyer & Rape, 
2014; Wickliffe et al., 2011). To circumvent this problem, auxiliary factors may facilitate 
chain assembly and ubiquitin binding domains appear to be the key to this process. Here, we 
provide a detailed molecular mechanism on how a UBD stimulates ubiquitin polymerization. 
We demonstrate that the CUE domain of Cue1 accelerates elongation of chains by specific 
binding events that coordinate the spatial arrangement of the E2 Ubc7 with the distal end of 
nascent chains.  
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RESULTS 
 
Helices α1 and α3 of the CUE domain bind the hydrophobic patch of ubiquitin. 
Thus far, structural studies on the yeast protein Cue1 have been limited to the Ubc7 binding 
region (U7BR) (Metzger et al., 2013). The importance of the CUE domain for K48-linked 
ubiquitin chain formation raised the question how ubiquitin binding and ubiquitin chain 
elongation are functionally connected (Bagola et al., 2013). As a starting point we used NMR 
spectroscopy to determine the structure of the CUE domain. This analysis unveiled a compact 
three-helical bundle characteristic for CUE and UBA domains (Figure 1A). Unlike canonical 
CUE domains, the CUE domain of Cue1 requires a C-terminal extension, which bears two 
phenylalanine residues for stable folding (Figure 1A, S1a A-F). In particular F108 is an 
essential part of the hydrophobic core (Figure S1a C). 
To study the interactions between the CUE domain and ubiquitin in more detail we performed 
NMR titration experiments with 15N-labeled CUE domain and unlabeled ubiquitin (Figure 
S1b A-E). Chemical shift perturbations (CSP) revealed that the most affected residues of 
CUE are located in the transition of helix α1 to the adjacent α1α2 loop (V73, L76, A77, N79) 
and in helix α3 (E96, E100, L103) (Figure 1B). The LAP76-78 motif corresponds to the strictly 
conserved MFP motif of other CUE domains. Quantitative analysis of the peak positions 
yielded a dissociation constant (KD) of 152 ± 5 µM (Figure S1b E). Using a reverse 
experimental set up, we mapped the interaction surface on ubiquitin (Figure 1B). Titration 
of 15N labeled ubiquitin with unlabeled CUE domain unveiled that binding involves the 
hydrophobic patch of ubiquitin centered around amino acids L8-I44-V70 and further includes 
R42, G47 and L71. Notably, the interaction surface on ubiquitin is in close proximity to the 
K48 residue without K48 directly contributing to binding (Figure 1C). 
Based on the chemical shift perturbation pattern we calculated a structural model of the 
CUE/ubiquitin complex using the software package HADDOCK (de Vries, Sjoerd J et al., 
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2010). This model supports a significant contribution of R42 in ubiquitin for the interaction 
with E100 of CUE (Figure 1C). At the same time this structural arrangement ensures that K48 
of ubiquitin is accessible for further chain elongation (Figure S1b F). 
 
Fluorescence-based analysis of ubiquitin chain elongation reactions 
Knowing the binding properties of the CUE domain we tried to understand how an interaction 
with ubiquitin stimulates ubiquitin chain formation by Ubc7. Therefore, we developed a 
fluorescence-based assay that allows to follow precisely elongation reactions of ubiquitin 
chains. Different chains of defined linkage and length were used as ubiquitin acceptors. These 
model substrates were blocked at their C-termini to prevent charging onto enzymes. 
Elongation of chains by single fluorescently labeled ubiquitin molecules was monitored using 
fluorescence anisotropy. In elongation experiments with tetraubiquitin the signal increased 
due to a slower tumbling of the formed pentaubiquitin when compared to labeled 
monoubiquitin (Figure 1D, 1E). This change in fluorescence anisotropy is strictly dependent 
on ATP. After subsequent addition of a deubiquitinating enzyme (Usp2cat), ubiquitin chains 
were completely disassembled and fluorescence anisotropy decreased to its original level. 
Reactions lacking preassembled chains did not show a rise in signal. In addition, elongation of 
tetraubiquitin was pursued by quantifying fluorescence intensities of the reaction product 
pentaubiquitin applying gel electrophoresis (Figure 1F, S1c B). Both experimental approaches 
yielded equivalent kinetics (Figure S1c A) supporting fluorescence anisotropy measurements 
to be a robust and precise tool to monitor chain elongation. Reaction catalysis required 
additionally an E1 enzyme (Ube1), the yeast E2 enzyme Ubc7 and the soluble fragment of 
Cue1 (cCue1, residues 25-203) which encompasses both the CUE domain and the U7BR. 
Some experiments included the cytosolic fragment of the E3 enzyme Hrd1 (cHrd, residues 
325-551) containing the RING-finger domain.  
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Ubiquitin binding affinity correlates with kinetics of chain elongation and substrate 
degradation 
In the absence of cCue1, chain elongation by Ubc7 was strongly impeded (Figure 2B). This 
observation can be attributed to the missing activation of the E2 enzyme by the U7BR 
(Metzger et al., 2013). To investigate the impact of the CUE domain on polyubiquitination, 
the structurally important LAP76-78 motif was replaced by RGA76-78 (cCue1 RGA; (Bagola et 
al., 2013)) which results in an unfolded CUE domain (Figure S1a F). Consistent with 
previously published data, reactions containing cCue1 RGA were substantially impaired for 
chain elongation (Figure 2B). In the presence of wild type cCue1, elongation of K48-linked 
tetraubiquitin (K48-Ub4) was fivefold faster than in the absence of a functional CUE domain, 
as indicated by the kinetic rate constants (Figure 2D). In line with this acceleration, the 
presence of a functional CUE domain increased the yield of elongation product (Figure 2F). 
Chain elongation did not require cHrd1, but was facilitated by addition of the RING domain 
(Figures 2B, 2C). The U7BR-bound Ubc7 has an increased affinity for its cognate E3 RING 
domain which in turn promotes discharging of ubiquitin from the E2, thereby driving 
ubiquitination (Metzger et al., 2013). 
To investigate whether ubiquitin binding of the CUE domain directly correlates with the 
propensity of Cue1 to enhance chain elongation, we substituted amino acids in the UBD 
involved in this interaction. These variants (E96A, E100A and L103A) retained the CUE-fold 
but weakened ubiquitin binding affinity as determined by NMR titration experiments (Figure 
2A, 2E, S2 A-B). While the E96 side chain does not contribute to ubiquitin recognition, 
binding activity was decreased for the E100A and even more for the L103A variant (as seen 
from the NMR titration experiments). Testing these cCue1 variants in elongation reactions 
with tetraubiquitin revealed a consistent correlation between binding affinities and kinetic rate 
constants. Wild type cCue1 ((4.87 ± 0.20) x10-3 s-1) and the E96A variant ((4.46 ± 0.13) x10-3 
s-1) exhibited comparable elongation kinetics. In contrast, reactions containing variants 
Kommentar [b1]: Wir haben auf Seite 
6 oben einmal von RING finger domain 
gesprochen. Ich glaube fortlaufend genügt 
die Bezeichnung RING domain, um ein paar 
Zeichen zu sparen. 
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E100A ((2.13 ± 0.05) x10-3 s-1) and L103A ((1.48 ± 0.03) x10-3 s-1) were 2-3 fold slower 
(Figure 2D). Accordingly, the total amount of the reaction product pentaubiquitin was 
reduced (Figure 2F). Similar effects on elongation kinetics were observed regardless, whether 
cHrd1 was present or absent (Figure 2C). Finally, we analyzed the Cue1 variants in vivo 
addressing polyubiquitin-mediated protein degradation. Ubc6 is a substrate of the DOA10 
ubiquitin ligase complex and as such degraded by proteasomes in a Cue1/Ubc7 dependent 
manner (Bagola et al., 2013). In line with a slower assembly of ubiquitin chains due to a 
weaker ubiquitin binding, Cue1 variants delayed the degradation of Ubc6 in yeast while 
complete absence of Cue1 or Ubc7 had a strong effect since in both cases the conjugating 
activity is missing (Figure 2G). Thus, a rapid elongation of ubiquitin chains by Ubc7 relies on 
specific ubiquitin binding events by the CUE domain of Cue1, and seems to be required for 
the efficient degradation at least of some  ERAD substrates. 
 
 
Ubiquitin chains with K48-linkages and growing length are preferentially elongated by 
cCue1/Ubc7 
Ubc7 exclusively assembles K48-linked polyubiquitin on substrates in vivo (Ravid & 
Hochstrasser, 2007; Choi et al., 2014) and unanchored ubiquitin chains in vitro (Bagola et al., 
2013). A substrate protein does not seem to be essential for polyubiquitination activity. 
Elongation reactions of monoubiquitin provide further evidence for a self-contained E2 
system with the task to extend ubiquitin chains. All experiments with cCue1/Ubc7 and 
ubiquitin chains revealed a stimulation of elongation due to the CUE domain. This is in 
contrast to reactions with monoubiquitin that show no enhancing effect of the UBD (Figure 
3A). 
To evaluate this function, we applied ubiquitin chains of different linkage and length as 
substrates in our fluorescence-based assay. Additionally, we examined whether changes in the 
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kinetics of chain elongation would correlate with differences in the binding affinities of the 
CUE domain by SPR and NMR experiments. In line with a modestly stronger interaction with 
K48-linked chains (Figure S3 A-D), we observed preferential elongation of K48- over K63-
linked substrates (Figure 3B, 3C, S3E, S3G, S3I). Distal elongation of the latter model 
substrate was ensured by K48R substitutions in all positions except at the distal ubiquitin. 
Besides the linkage type of a substrate, its size also influenced the elongation rate (Figure 3B). 
Increasing chain length accelerated elongation kinetics in the presence of the CUE domain, 
which can be explained by higher local concentrations of Ubc7 in the surrounding of chains 
due to more binding sites. This effect is again modestly more pronounced for K48-linked 
chains than for K63-linked substrates corresponding to the higher affinity of CUE to K48-
linked ubiquitin. 
cCue1 RGA was employed in kinetic analyses to evaluate the capability of U7BR-bound 
Ubc7 to elongate chains. Without a functional CUE domain, reactions with 
cCue1/Ubc7/cHrd1 were remarkably slow (Figure 3D, 3F S3F, S3H, S3J). In line with the 
general constraint of polyubiquitination lacking auxiliary ubiquitin binding events (Meyer & 
Rape, 2014; Wickliffe et al., 2011) elongation was decelerated with increasing chain length, 
an effect more pronounced for K48- than for K63-linked chains. Next, we determined the 
degree of acceleration caused by the CUE domain to assess its function in chain elongation. 
The CUE domain specific factor is set as the ratio of kinetic rate constants from reactions with 
wild type cCue1 to reactions with cCue1 RGA and attained higher values for K48-linked 
chains than for K63-linked chains (Figure 3E). Moreover, the acceleration increased from 
K48-linked di- to tetraubiquitin, which was not observed for K63-linked chains. In summary, 
these results indicate that the CUE domain of Cue1 progressively accelerates elongation of 
K48-linked chains with increasing length counteracting the inability of Ubc7 to rapidly 
elongate growing chains. 
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CUE binds the proximal moiety of K48-linked diubiquitin with higher affinity than the 
distal molecule 
To understand, why the CUE domain shows a small but significant preference for K48-linked 
chains, we synthesized K48- and K63-linked diubiquitin containing 15N-labeled moieties at 
either the proximal or distal position. Upon titration with unlabeled CUE domain, binding 
events at one of both positions could be analyzed. Chemical shift perturbations suggested that 
the interfaces of interaction with Cue1 are similar on mono- and diubiquitin (Figure 4A-D). 
However, we observed one interesting difference between the associations to K63- and K48-
linked diubiquitin. The latter displayed an additional interaction event involving position G75 
at the C-terminus of the distal ubiquitin moiety. Since the K48 residue of ubiquitin is in close 
proximity to the CUE binding site, this additional interaction specifically results from K48-
linked monomers. Employing a binding model assuming two different binding sites in 
diubiquitin we quantitatively analyzed NMR titration experiments and calculated KD values 
(Figure 4E, 4F, S4). In K48-Ub2 the CUE domain preferentially binds proximal ubiquitin (84 
± 8 µM) approximately twofold tighter than distal ubiquitin (151 ± 13 µM). In contrast, no 
difference in affinity for distal and proximal binding was detected for K63-linked diubiquitin 
(~100 µM; Figure 4F). Interestingly a previous study has presented similar binding analyses 
involving the CUE domain of the mammalian ERAD E3 gp78 revealing a preference for the 
distal moiety in K48- and K63-linked diubiquitin (Liu et al., 2012) reflecting a different 
organization in this ubiquitin ligase. 
 
CUE domain binding adjacent to the distal acceptor ubiquitin promotes chain 
elongation 
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Finally, we wanted to know whether the influence of the interaction of Cue1 with K48-linked 
ubiquitin molecules on the chain elongation is position dependent. Thus, we introduced the 
amino acid exchange R42A in either moiety of diubiquitin (Figure 5A). Monoubiquitin R42A 
displays reduced binding to the CUE domain (KD = 600-700 µM, Figure 3C). When placed in 
the distal molecule that serves as an acceptor for ubiquitin conjugation, the R42A variant had 
a negligible effect on elongation kinetics. In contrast, R42A at the proximal position reduced 
elongation in rate and efficiency. These findings suggest that binding of Cue1 to the proximal 
ubiquitin adjacent to the acceptor site promotes polyubiquitination. Elongation experiments of 
these diubiquitin molecules in the presence of cCue1 RGA exhibited almost identical reaction 
kinetics indicating that the observed position effect is CUE domain specific. Moreover, the 
UBD stimulated reactions in the presence of cHrd1 implying Cue1 to act as a prevalent 
scaffold for ubiquitin chains (Figure S5A). 
We now wondered how CUE binding within longer chains affects the elongation kinetics. 
K48-Ub4 variants with single R42A amino acid exchanges in different ubiquitin moieties 
feature an equal number of binding sites and enabled us to map the action profile of the CUE 
domain. Again, analysis of chain elongation kinetics yielded the most pronounced effect by 
introducing the R42A variant adjacent to the distal acceptor ubiquitin (Figure 5B, S5B, S5D). 
For this substrate the slowest elongation reaction was observed (~70% of wild type rate 
constant). Introducing multiple R42A ubiquitin variants in Ub4 decelerated elongation even 
further (Figure 5C, S5C, S5E). These data suggest that binding of cCue1 to any moiety within 
the chain accelerates the elongation reaction. However, the degree of stimulation depends on 
the position of the interaction within a chain, showing the highest impact when placed next to 
the acceptor ubiquitin. This effect is independent of linkage type and can also be measured for 
K63 linked diubiquitin (Figure S5F) suggesting that interaction with the ubiquitin molecule 
next to the acceptor site provides the optimal steric arrangement for Ubc7 based chain 
elongation. 
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To validate the importance of the position effect we restricted CUE-ubiquitin interactions to 
certain positions within a chain. Therefore, we chemically crosslinked the single cysteine 
variant of cCue1 (T66C, C147S) with different ubiquitin (T9C) moieties (Figure S5G). 
Crosslinking cCue1 to the proximal moiety in diubiquitin showed a drastic increase of the rate 
and efficiency of chain elongation (Figure 5D). Chain elongation was slower when cCue1 was 
crosslinked to the proximal position in triubiquitin. In contrast crosslinking to the distal 
position of diubiquitin had an inhibitory effect. This strong acceleration of the chain 
elongation by crosslinking to the positions adjacent to the acceptor site supports our model. 
 
 
DISCUSSION 
 
Shaping a ubiquitin chain represents an intriguing steric problem. The longer a chain grows, 
the larger is the distance to the active center of the involved E2-E3 ligase complex. In a 
stochastic process the growth of ubiquitin chains should slow down with increasing length of 
a chain. This general constraint in polyubiquitin formation was previously reported (Meyer & 
Rape, 2014; Wickliffe et al., 2011). It is consistent with our kinetic measurements of the E2 
Ubc7 activity missing a functional UBD. Here, we present a mechanism on how the presence 
of the CUE domain in Cue1 counteracts this effect by directing Ubc7 to acceptor lysine 
residues at a distal ubiquitin molecule of a nascent ubiquitin chain. This leads to a 
progressively accelerated elongation reaction with increasing chain length. 
Corresponding to the K48-linkage specificity of Ubc7 (Bagola et al., 2013), CUE features a 
modestly stronger binding to K48-linked ubiquitin assemblies than to other chain types. The 
preference is caused by additional interactions at the C-terminus of the neighboring ubiquitin 
molecules in these chains. In consequence, linked moieties in a chain are bound twofold 
stronger than the distal one. Furthermore, we observed an unconventional binding interface 
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compared to consensus CUE domains. K48 of ubiquitin is excluded from the binding 
interface with Cue1 while for instance the CUE domain of Cue2 directly involves K48 thus 
potentially blocking it for further modifications (Kang et al., 2003). The accessibility of this 
lysine residue is a prerequisite for chain formation by Ubc7. Consistent with the binding 
preference, K48-linked chains are elongated faster than K63-linked model substrates in the 
presence of the CUE domain. However, since the Ubc7 system within ERAD is based solely 
on K48 linked chains, there was no evolutionary pressure to optimize the system for K48 
versus K63 linkage types, explaining the relatively small differences observed for the 
interaction of the CUE domain with both chain assemblies. In summary, CUE binding 
converts an inherent decelerating chain formation by Ubc7 into a self-accelerating process. 
Based on our kinetic analysis, we suggest two major factors increasing the pace of chain 
assembly. First, the number of binding sites: Reducing the number of binding sites by 
introducing specific variants into ubiquitin chains or the CUE domain decelerates elongation 
reactions. This includes also the acceptor ubiquitin moiety and strongly indicates that multiple 
interactions of Cue1 with a ubiquitin chain increases the local concentration of Ubc7 which in 
turn promotes chain elongation. 
Second, the position of CUE binding: A deficient binding to the ubiquitin moiety adjacent to 
the distal end of a chain has a greater impact on the rate of chain assembly then at other 
positions. In addition crosslinking of cCue1 with ubiquitin at this position enhanced chain 
elongation most. An interaction of Cue1 with the penultimate ubiquitin in a chain most likely 
orientates Ubc7 to the distal end of a ubiquitin chain to productively transfer ubiquitin from 
the charged E2 to the acceptor lysine of the distal moiety. Binding to ubiquitin further away 
from the distal end shows a diminished stimulation due to an increasing distance from the 
ubiquitin acceptor molecule. 
In comparison to a recently reported mode of chain formation described in cell cycle control, 
our proposed mechanism seems to be perfectly adapted to rapid proteolytic processes of 
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substrates with divers biophysical properties, like in the case of the ERAD system (Kelly et 
al., 2014). The APC/C is a tightly adjusted system for regulatory degradation of cell cycle 
protagonists and simultaneously coordinates recognition and ubiquitination of a limited pool 
of defined substrates. Here, the RING domain increases the affinity of the E2 Ube2S to the 
distal ubiquitin molecule whereby chain elongation is enhanced. Tracking the end of chains is 
a stimulating effect, which subsides with increasing chain length. ERAD challenges ubiquitin 
ligases with a much wider range of target proteins, although not all ERAD substrates seem to 
depend on the presence of a CUE domain (Bagola et al., 2013). In order to achieve rapid 
removal of substrates with diverse biophysical properties, robust K48-linked chain formation 
must be guaranteed. In contrast to a self-limiting ubiquitination in cell cycle control, ERAD 
employs a self-accelerating chain assembly when Cue1 is involved. At the APC/C the 
contribution of the RING domain in an enhanced polyubiquitination directly connects 
substrate binding and ubiquitination. In contrast Cue1/Ubc7 may represent a self-contained 
module, adapted to quickly assemble K48-linked chains on diverse substrates in concert with 
different ubiquitin ligases. Recognition of certain substrate classes and their cytosolic 
ubiquitination seems to be disconnected at ERAD ubiquitin ligases. In the case of Hrd1, 
substrate recognition occurs at the ER-luminal Hrd3 domain of the ligase complex (Carvalho 
et al., 2006; Denic et al., 2006). This may avoid steric clashes of fixed substrates and growing 
chains. 
Based on our results, we want to propose the following model for a UBD-mediated 
polyubiquitination by Ubc7 (Figure 6). In a first step, substrate proteins are ubiquitinated on 
one or several lysine residues. Here, contribution of the CUE domain is probably limited to 
shield initial modifications from deubiquitinating enzymes (Bagola et al., 2013). As soon as 
the substrate is primed with diubiquitin, the machinery switches to highly processive chain 
elongation. Cue1 binds the moiety adjacent to the acceptor ubiquitin and orients Ubc7 for 
ubiquitin transfer. The preference of the CUE domain for K48-linked molecules enhances this 
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position effect and keeps the distal ubiquitin accessible. The CUE domain binds individual 
ubiquitin moieties with low affinity allowing dynamic motions within the growing chain. 
Since the off-rate of the CUE domain – ubiquitin complex is much faster than the rate of the 
enzymatic reaction, a higher number of binding sites within the growing chain does not 
inhibit the overall reaction but accelerates it by keeping the E2 in close proximity to the 
growing chain and at the same time allowing the system to sample all possible interaction 
positions efficiently. While the absolute acceleration effects are relatively small (factor 2-5) as 
compared to typical acceleration effects of enzymatic reactions with small molecules, they are 
within the same range as observed for other interactions within ubiquitin system (Metzger et 
al., 2013). The CUE domain enables Cue1 to act in an E4-like fashion by implementing an 
acceleration factor of chain elongation. Our data suggest that in the absence of a functional 
CUE domain, ubiquitin chains should be formed less efficiently on specific ERAD substrates. 
In line with this prediction we found that variants with reduced affinity of the CUE domain 
delayed proteasomal degradation of the ERAD substrate Ubc6 in vivo. Since Ubc6 
degradation has also been shown to involve priming of the substrate with K11-linked chains 
the CUE domain might also contribute to K11-chain extension (Kreft & Hochstrasser, 2011; 
Xu et al., 2009). Strikingly, decelerated chain synthesis is neither compensated by 
downstream acting E4 enzymes at the level of Cdc48 nor by the proteasome (Schmidt et al., 
2005; Crosas et al., 2006; Jentsch & Rumpf, 2007). Hence, turnover kinetics seem to be 
directly defined by the efficacy of the primary ubiquitination.  
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EXPERIMENTAL PROCEDURES 
 
Protein purification for structural and interaction studies 
The codon optimized gene of Cue125-203 and related constructs containing only the CUE 
domain were expressed as polyhistidine tagged ubiquitin fusion proteins (Rogov et al., 2012). 
Expression was carried out in T7 Express competent E. coli. Cells were grown in LB or M9 
medium and induced at 18 °C for 20 h with 0.2 mM IPTG. Purification included lysis, 
Immobilized Metal Affinity Chromatography (IMAC), tag removal by TEV protease, a 
second IMAC step followed by gel filtration. 
To biotinylate the CUE domain a biotinylation site was introduced between the TEV site and 
the coding sequence of Cue159-115. In vitro biotinylation was performed in 50 mM bicine (pH 
8.3), 10 mM ATP, 10 mM MgOAc and 50 µM biotin using BirA for 1h at 30 °C. 
 
Protein expression, purification and fluorescence labeling for functional analysis 
Ubc7, Hrd1325-551 (cHrd1), Cue125-203 (cCue1) and Cue125-203 variants were cloned in a pGEX-
6p1 vector, expressed and purified as described before (Bagola et al., 2013). Ube1 subcloned 
in a pET21d vector was produced according to a published protocol (Berndsen & Wolberger, 
2011). Cdc34, Ubc13 and Uev1a in pGEX vector were expressed and processed as previously 
reported (Mansour et al., 2014). The catalytic domain of the deubiquitinating enzyme Usp2 
(Usp2cat) was purchased from Boston Biochem. Human ubiquitin (Ub) and all its variants, 
cloned in pETM60, were expressed in E. coli BL21 cells and produced according to previous 
protocols (Pickart & Raasi, 2005; Mansour et al., 2014). Labeling of cysteine containing 
ubiquitin variants with the fluorescence dye Alexa Fluor 488 C5 Maleimide has been 
described (Bagola et al., 2013). 
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Preparative assembly of ubiquitin chains 
Ubiquitin chains with proximal hexahistidine tag (6xHis) were enzymatically assembled in 
vitro. K48-linkages were synthesized using Cdc34, while K63-linked chains were generated 
by Ubc13 and Uev1a. A detailed description of the reaction conditions is available in 
Supplemental Experimental Procedures. 
 
NMR spectroscopy 
NMR experiments were performed at 298K in NMR buffer (50 mM Na2HPO4, 100 mM 
NaCl, pH 7, 5% D2O). NMR structure determination of 13C-15N-labeled Cue145-115 followed a 
standard protocol (see Supplemental Information). 
Titration of 15N-labeled ubiquitin with CUE or 15N-labeled CUE (0.2 mM) with Ub or Ub 
chains was monitored by [15N, 1H]-HSQC spectra. Spectra were acquired at CUE:Ub molar 
ratios of 0, 1/8, 1/4, 1/2, 1, 3/2, 2, 4, 8 and 16 (only in case of monoubiquitin titration). Since 
a ubiquitin chain presents multiple binding sites for CUE the molar ratios were accordingly 
corrected. 
The structural model of the CUE/ubiquitin complex was calculated in HADDOCK. 
Ambiguous interaction restraints (AIR) were defined for solvent accessible amide resonances 
shifting more than 0.10 ppm under saturation for CUE, and 0.12 ppm for ubiquitin. 
K48-Ub2 (0.2 mM) and K63-Ub2 (0.2 mM) carrying either a proximal or distal 15N-labeled 
ubiquitin were titrated with unlabeled Cue145-115 up to a molar ratio of 8. To determine the 
dissociation constants for proximal and distal ubiquitin moieties a fitting model for two 
independent binding sites with different affinities was used (Varadan et al., 2005; Wang & 
Jiang, 1996). 
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CD spectroscopy 
CD spectroscopy experiments were performed using a JASCO J-810 spectropolarimeter 
(JASCO, USA) in a 0.1 cm pathlength cuvette. Temperature induced unfolding was 
monitored by ellipticity changes at 222 nm from 4 to 90°C. Protein concentrations were 
adjusted to 100 μM in NMR buffer. 
 
In vitro ubiquitin chain elongation reaction for fluorescence based analysis 
In vitro ubiquitination reactions (performed in triplicates) modified for analysis of ubiquitin 
chain elongation included 0.15 μM E1 (Ube1), 2 μM Ubc7, 1.2 µM cCue1 or variants, 14.8 
µM preassembled ubiquitin chains and 0.2 µM Alexa Fluor 488 labeled Ub in FA buffer (4 
mM ATP, 0.5 mM DTT, 4 mM MgCl2, and 50 mM Tris/HCl pH 8). Optionally 1 μM cHrd1 
was added. Reactions of time course experiments were performed in the dark at 10 °C 
containing cHrd1 or at 20 °C omitting the RING fragment. In another set of chain elongation 
experiments cCue1 was crosslinked to Ub T9C which was integrated either at the distal (K48-
Ub2distal~cCue1) or proximal position (K48-Ub2proximal~cCue1) of diubiquitin or the proximal 
position of triubiquitin (K48-Ub3proximal~cCue1). Crosslinking reactions with BM(PEG)2 were 
carried out according to the manufacturer's manual. Conjugates were included in in vitro 
ubiquitination reactions and performed in triplicates. Reactions included 0.15 μM E1 (Ube1), 
2 μM Ubc7, 1.2 µM cCue1 T66C C147S crosslinked to Ub T9C (in Ub2 or Ub3), 0.2 µM 
Alexa Fluor 488 labeled Ub in FA buffer. A similar reaction without crosslinked conjugates 
contained equal amounts of cCue1 and K48-Ub2 (1.2 µM). 
At given time points samples were taken and elongation was stopped using urea sample 
buffer. Elongation reactions monitored by fluorescence anisotropy were carried out at 20 °C. 
Polarized emissions at 518 nm after excitation at 495 nm were measured in a 
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Spectrofluorometer (Fluoromax 4, Horiba). For subsequent deubiquitination 500 nM Usp2cat 
was added after saturation of chain elongation. 
Elongation products were analyzed by SDS-PAGE following fluorescence scanning 
employing emission filter LPB (510LP) after excitation at 473 nm and Coomassie Brilliant 
Blue staining. 
Fluorescence intensities of elongation products were quantified using ImageQuant TL 
software and normalized to total fluorescence signals. Single exponential elongation kinetics 
were analyzed with FluorEssenceTM Software and SigmaPlot Version 12  yielding kinetic rate 
constants of elongation reactions. 
 
SPR studies 
SPR experiments were performed on a Biacore X100 system. Biotinylated CUE was 
immobilized (~100 RU) on a streptavidin coated sensor chip. All experiments were carried 
out in buffer containing 10 mM HEPES (pH 7.4), 150 mM NaCl, 3 mM EDTA and 0.05% 
Tween 20. Ub and Ub chains were injected at concentrations of 0, 2, 4, 10, 25, 50, 100, 200, 
400 and 800 µM at a flow rate of 50 µl/min (100 s injections). In case of polyubiquitin chains 
the concentrations were adjusted according to the number of ubiquitin molecules. 
Dissociation constants were calculated using the BiaEvaluation software from control-
corrected steady-state response units. This yielded apparent dissociation constants for a single 
ubiquitin within a chain under the assumption that all binding sites are equal. 
 
Cycloheximide Decay Assay 
Protein degradation was analyzed in yeast cells by means of blocking translation. 25 OD600 of 
cells in log-phase were suspended in SD medium containing 0.35 mg/ml Cycloheximide and 
incubated at 30 °C. 500 µl of ice-cold 30 mM NaN3 and 1mM PMSF stopped degradation 
after 1, 2 and 3 hours. Cells were lysed by glass beads and strong agitation in 50 mM 
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Tris/HCl pH 7.5, 1 % (w/v) SDS and 1 mM PMSF. Ubc6, Sec61 and Cue1 were analyzed by 
SDS-PAGE and Western blotting according to (Bagola et al., 2013). 
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FIGURE LEGENDS 
 
Figure 1: The interaction of the CUE domain with ubiquitin and fluorescence 
anisotropy-based analysis of ubiquitin chain elongation reactions 
(A) Superposition of the NMR solution structure (PDB code: 2MYX) ensemble comprising 
the 20 lowest energy conformers. The three α-helices are colored in yellow, green and cyan 
(from N to C terminus), whereas the structured regions following and preceding the three 
helices are colored in blue (C-terminal extension) and red (N-terminal extension). The LAP 
motif is highlighted in orange. See also Figure S1a. 
(B) Mapping of affected residues upon binding onto the structure of the CUE domain and 
ubiquitin (PDB code: 1UBQ). The structures are shown as a ribbon diagram as well as a 
surface representation. Residues shifting more than 0.12 ppm are colored in yellow and 
residues shifting more than 0.18 ppm in red for Cue1. For ubiquitin, residues shifting more 
than 0.13 ppm are shown in yellow, whereas residues shown in red shifted more than 0.22 
ppm. See also Figure S1b. 
(C) Model of the CUE/ubiquitin complex. The highest scored structural model from a CSP-
based HADDOCK structure calculation is shown. The structure reveals the importance of R42 
of ubiquitin for complex formation. CUE is bound in close proximity to the K48 residue, the 
site of further chain conjugation, however, K48 itself remains completely accessible. 
(D) Ubiquitin chains are elongated in vitro by one ubiquitin moiety. Due to a C-terminal His6-
tag preassembled chains only serve as an acceptor for ubiquitin. Fluorescently labeled 
ubiquitin is activated by the E1 enzyme and transferred to the E2 enzyme Ubc7. In concert 
with the cytosolic fragment of Cue1 (cCue1) Ubc7 elongates ubiquitin chains that are 
employed in excess. The RING domain of Hrd1 (cHrd1) is optionally added to facilitate the 
reaction. See also Figure S1c. 
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(E) In fluorescence anisotropy measurements a rising signal monitors the elongation of K48-
linked tetraubiquitin (―). After subsequent addition of a deubiquitinating enzyme (Usp2cat) 
anisotropy signals decrease (―) close to the baseline of reactions omitting ATP (―). 
Reactions lacking ATP or preassembled ubiquitin chains (―) do not show an increase in 
anisotropy. 
(F) The yield of elongation products was determined by SDS-PAGE, fluorescence scanning 
and Coomassie staining. Added Usp2cat is marked with an asterisk (*). 
 
Figure 2: The ubiquitin binding affinity of the CUE domain correlates with the kinetics 
of ubiquitin chain elongation reactions in vitro and the degradation of the ERAD-
substrate Ubc6 in vivo. 
(A) Superposition of a section of [15N, 1H]-HSQC spectra recorded for cCue1 variants E96A, 
E100A, L103A in presence (8-fold molar excess of ubiquitin ●) and absence of ubiquitin (●). 
As a reference the spectrum recorded for the wild type CUE domain in presence of the same 
amount of ubiquitin is shown (●) (See also Figure S2). Binding of the E96A variant resembles 
the wild type protein, while variants E100A and L103A show diminished affinities. 
Substitutions in the LAP motif L76R A77G P78A (cCue1 RGA) result in an unfolded CUE 
domain (Figure S1a F) and prevent an interaction with ubiquitin. 
Fluorescence anisotropy traces were obtained from K48-Ub4 elongation reactions with Ubc7 
and cCue1 (―) or cCue1 variants (E96A ―, E100A ―, L103A ―, RGA ―) in presence (B) 
or absence of cHrd1 (C). Solid lines show monoexponential fits of the data points on which 
basis kinetic parameters were calculated. 
(D) Rate constants of elongation reactions of tetraubiquitin with cCue1 or variants in (B). 
(E) Chemical shift perturbations (CSPs) of representative residues (V73, L76, A77) upon 
ubiquitin binding. Obtained shifts at 8-fold molar excess of ubiquitin are compared between 
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wildytpe and CUE domain variants. The ratio between the CSPs observed for the wildtype 
CUE domain and its variants was calculated. 
(F) The yield of assembled elongation product pentaubiquitin of reactions in (B) is calculated 
by the ratio of fluorescent pentaubiquitin over non-conjugated fluorescently-labeled 
monoubiquitin. 
 (G) Quantification of a cycloheximide based decay assay of Ubc6 performed in presence of 
the Cue1 variants (Figure S2C). The kinetics of degradation are color-coded as in B. The 
quantities of variant proteins were similar throughout the experiments. Remaining amounts of 
Ubc6 from ∆cue1 and ∆ubc7 strains (data from a separate experiment) provide a baseline and 
indicate maximal delay of Ubc6 degradation. 
 
Figure 3: The CUE domain of Cue1 preferentially binds K48-linked ubiquitin chains 
and stimulates their elongation. 
(A) Kinetics of monoubiquitin (―) and diubiquitin (---) elongation by Ubc7 and cCue1 (―) 
or cCue1 RGA (―) monitored by time course experiments. The CUE domain stimulates 
elongation of ubiquitin chains but not of monoubiquitin. 
(B) Kinetic rate constants of elongation reactions with cCue1 and Ubc7 for a set of ubiquitin 
chains linked via K48 or K63 (Figure S3 A-F). K63-linked model substrates are restricted for 
distal elongation by K48R ubiquitin variants except at the distal moiety. Reactions accelerate 
from top to bottom with K48-Ub4 elongated fastest. 
(C) KD values for the interaction between the CUE domain and different ubiquitin chains 
were calculated from SPR binding data assuming a 1:1 binding model with multiple, 
independent and equal binding sites. 
(D) Kinetic rate constants of elongation reactions with Ubc7, cHrd1 and cCue1 (■) or cCue1 
RGA (■) are shown in comparison for different substrate chains. 
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(E) Acceleration factors which quantify the CUE specific stimulation were calculated as a 
ratio of kinetic rate constants of reactions with wild type Cue1 and rate constants of reactions 
with Cue1 RGA (■). The stimulating effect of the CUE domain is most pronounced for K48-
linked chains and rises with increasing chain length for this linkage type. 
(F) A working model of cCue1/Ubc7 illustrates ubiquitin chain elongation in presence and 
absence of CUE domain´s binding activity. 
 
Figure 4: The CUE domain preferentially binds the proximal moiety in K48-linked 
diubiquitin 
(A) Backbone amide CSP mapping of 15N-labeled proximal ubiquitin or 15N-labeled distal 
ubiquitin in K48-Ub2 upon titration with unlabeled CUE domain. Proximal ubiquitin and the 
resulting CSPs are colored blue, distal ubiquitin and the corresponding CSPs red. Since the 
backbone amide signal of R42 disappeared the indicated CSP of R42 was set to the arbitrary 
value of 0.5 to emphasize its importance in mediating CUE recognition. The CSP of G75 in 
distal ubiquitin is colored in blue because we propose that this represents an additional 
interaction with proximally bound CUE. 
(B) The same data as in A for K63-Ub2. 
(C) Overlay of a representative section of the [15N, 1H]-HSQC spectra showing the unbound 
form of proximal/distal ubiquitin in black and the spectra recorded at a 1:1 molar ratio of 
CUE:Ub2 either with proximally (blue) or distally (red) 15N-labeled samples. Larger shifts for 
proximal ubiquitin indicate a significantly higher population of proximally bound CUE. 
(D) The same overlays as in C for K63-Ub2. CUE interactions with proximal and distal 
ubiquitin of K63-Ub2 are similar. 
(E, F) Determination of KD values from the CSP data. The data was fitted assuming a binding 
model with two independent but different binding sites. The fit reveals a two fold increase in 
affinity for proximal K48-linked ubiquitin. See also Figure S4. 
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Figure 5: An interaction of the CUE domain with the moiety adjacent to the distal 
acceptor ubiquitin strongly promotes chain elongation. 
(A) Elongation of diubiquitin catalyzed by Ubc7 and cCue1 (―) or cCue1 RGA (―) was 
followed by time course experiments. The kinetics of reactions with wild type diubiquitin (●) 
and a variant with distal R42A ubiquitin (▼) were similar in presence of cCue1. In contrast, 
the elongation of diubiquitin containing a proximal R42A ubiquitin was significantly 
decelerated (■). Reactions with this set of diubiquitin molecules and cCue1 RGA exhibited 
almost identical kinetics. 
(B) Kinetic rate constants of elongation reactions with cCue1, Ubc7 and K48-Ub4 variants 
bearing single R42A ubiquitin molecules (Figure S5B, S5D). Deceleration of chain 
elongation is most pronounced for R42A that is located in the moiety adjacent to the distal 
acceptor ubiquitin. cCue1 binding at this position in tetraubiquitin as well as distal chain 
elongation by Ubc7 are schematically depicted in our working model. 
(C) Kinetic rate constants of reactions with cCue1, Ubc7 and K48-Ub4 variants that contain 
multiple R42A substitutions. An increasing number of substitutions progressively decelerates 
elongation kinetics (Figure S5C, S5E). 
(D) Elongation reactions with cCue1 T66C C147S crosslinked to Ub T9C which is placed at 
different positions in ubiquitin chains are monitored by time course experiments. Crosslinking 
cCue1 to the distal position of K48-linked diubiquitin (K48-Ub2distal~cCue1, ―) strongly 
decelerates elongation. cCue1 fixed at proximal sites of di- (K48-Ub2proximal~cCue1, ―) or 
triubiquitin (K48-Ub3proximal~cCue1, ―) yields fast kinetics. Reactions without crosslinking 
were performed with equimolar amounts of cCue1 and K48-Ub2 (―)as a reference. See also 
Figure S5 F-G.  
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Figure 6: Model of the Cue1-CUE domain-assisted ubiquitin chain assembly by Ubc7 
The CUE domain of Cue1 binds single moieties of ubiquitin chains and aligns the E2 Ubc7 
with the distal end of the polymer. Binding events adjacent to the acceptor ubiquitin promote 
chain elongation most. In addition, longer chains keep the E2 enzyme in close proximity to 
the acceptor ubiquitin.  
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